Global Human Milk Oligosaccharides (HMO) Market is anticipated to grow considerably in the coming years due to rise in demand for infant nutrition food products. Human milk oligosaccharides are the complex sugars that are produced in the breast milk by mothers in large quantities. They can be assumed as the fibers that cannot be consumed by the newborns. HMO build bifidobacteria that helps in several mechanisms. It prevents the growth of other pathogens in the same environment.
The
drivers of human milk oligosaccharides market include speedy technological
improvements in product line, rise in application in the infant supplements,
growing application in food and beverages and increasing use in dairy sector.
Moreover, change in lifestyle, rise in health awareness and rising demand for
human milk donors are expected to drive the market growth. However, low
availability of raw materials and high priced chemical and enzymatic synthesis
techniques, lack of technical expertise and significant R&D cost are
hampering the market growth.
Request Sample Copy of This Market Research @
Nevertheless,
leading players adopting merger& acquisition, affiliations and
collaboration strategy and improvements in supply chain management are a few
trends in human milk oligosaccharides industry. Moreover, future investments
are expected to bring opportunities for the market players.
Human
milk oligosaccharides market is categorized on the basis of type, application
and geography. On the basis of type, the market is divided into LNT &LNnT,
sialyllactose and fucosyllactose. Fucosyllactose segment is predicted to hold
larger market share due to rising use in infant supplements.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/human-milk-oligosaccharides-hmo-market
Based
on application, HMO industry is divided into food & beverages, health
ingredients for human & animal, infant formulas and food supplements.
Infant supplement segment leads the HMO market due to the increasing number of child
malnourishment cases and growth in mortality.
Geographically,
human milk oligosaccharides industry is segmented as North America, Latin
America, Europe, Asia Pacific and Middle East & Africa. North America
followed by Europe are erected to dominate the market of human milk
oligosaccharides due to increasing number of manufacturers and rise in demand
for infant formulas in Italy, France, Spain and U.K. Europe and Asia Pacific
are also projected to lead in future due to increasing demand for nutritional
food products.
The
prominent players in human milk oligosaccharides (HMO) industry include Abbott,
Dextra Laboratories, Inbiose, Jennewein Biotechnologie GmbH, Glycosyn LLC,
Glycom A/S, ZuChem, Inc., Elicityl SA and Medolac Laboratories.